PIK3CA mutations are prevalent in 5–25% of ATCs and 0–11% in PDTCs; AKT1 mutations in 0–8% of ATCs and 0–13% of PDTCs; and PTEN mutations in 10–15% of ATCs. The gene discussed is PIK3CA; the disease is Ehlers-Danlos syndrome, musculocontractural type.